CD274 and neoplasm: In order to evade antitumor immunity T cell mediated pathway, some tumor cells produce the programmed cell death-ligand 1 (PD-L1) and reduce T cells activation through bonding at a down regulated receptor, PD-1, on surface T cells 20-22.